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ABSTRACT
INTRODUCTION: Verapamil is a drug that is used often due to its wide spectrum of action. Many authors 
consider it to be the most dangerous of the calcium channel blockers due to its negative chronotropic and 
inotropic effect on the heart, leading to severe cardiodepression. Overdose is difficult to treat and is associ-
ated with high mortality despite existing treatment options.
Over the last 15 years, lipid emulsions (LEs) have been increasingly used for resuscitation after overdosing 
with lipophilic drugs such as verapamil. Despite the convincing results and the improved patient status, the 
association of the administration of LE with the recovery of patients may be questioned since LE was given 
in addition to standard therapy. 
AIM: The aim of this article is to conduct an evaluation of the self-cardioprotective effect of LE in acute 
verapamil overdose (15 mg/kg) in rats by measurement of the heart rate and survival at the recommended 
LE dose of 1.5 mL/kg and 7 times the recommended LE dose (10 mL/kg).
MATERIAL AND METHODS: The experiment was performed on 30 male Wistar rats, provided by the Med-
ical University of Varna. Instrumental methods included monitoring the heart rate of rats using an electro-
cardiographic monitor. The statistical analysis was performed using the statistical functions in Excel 2016 
and Statistica 7.0. 
RESULTS: A survival rate of 100% was observed in rats pretreated and treated with low and high LE dose. 
The high LE dose (10 mL/kg) showed a faster improvement in cardiac function as the highest mean heart 
rates were established.
CONCLUSION: Pretreatment and resuscitation with low or high LE dose reduce toxicity and prevent dose-
dependent asystole induced by verapamil. The administration of a high LE dose (10 mL/kg) proved to be 
more effective in terms of heart rate in rats.
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INTRODUCTION
Acute drug intoxication is a major problem 
worldwide, with antidepressants, neuroleptics, and 
cardiovascular drugs being the most commonly 
overdosed drugs. Most of these do not have a specific 
antidote and cause serious and sometimes fatal car-
diovascular and neurological complications, neces-
sitating the introduction into the routine practice of 
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more effective treatments such as intravenous lipid 
emulsions (LEs).
Initially, LEs were developed to meet the neces-
sity for essential fatty acids in patients receiving par-
enteral nutrition. In the last 15 years, a new effect of 
LEs has been discovered, initially for the treatment of 
local anesthetic systemic toxicity (LAST), and subse-
quently, their ability to capture lipophilic drugs and 
extract them from target organs, thus reducing their 
toxicity. This phenomenon is known as “lipid sink”. 
According to it, the rapid application of the LE into 
the bloodstream creates a lipid phase that absorbs li-
pophilic xenobiotics and prevents them from bind-
ing to target receptors. A concentration gradient is 
created, which allows toxins to be quickly removed 
from areas of high accumulation (brain, heart). In-
troduced by Weinberg in 1998, it is the most wide-
ly accepted mechanism of antidote action of LEs (1).
Over the last 15 years, LEs have been increas-
ingly used in toxicological and intensive depart-
ments for resuscitation after overdosing with local 
anesthetics and lipophilic drugs. The dose deter-
mined by the American Society of Regional Anes-
thesia (ASRA) is a bolus intravenous dose of 1.5 mL/
kg for one minute, followed by a continuous intrave-
nous infusion of 0.25 mL/kg/min for 20–60 minutes 
until circulation is restored (2).
Despite the convincing results and the im-
proved patient status, the association between the 
administration of LE with the recovery of patients 
can be questioned. Lipid emulson was given in ad-
dition to standard therapy and the effect of LE could 
not be associated with improving the clinical status 
of patients.
Verapamil is a calcium channel blocker that is 
used extremely often due to its wide spectrum of ac-
tion: supraventricular arrhythmias, arterial hyper-
tension, coronary heart disease, cerebral reperfu-
sion, dysmenorrhea, migraine and others. Due to its 
strong cardiodepressive, negative chronotropic and 
inotropic effects, this drug is the most toxic calcium 
channel blocker and causes severe intoxication in 
case of overdose (3). 
Despite the treatment, about 5% of the cases die 
(4). The parameters of cardiotoxicity include change 
in blood pressure, change in heart rate, rhythm and 
conduction disorders (5, 6, 7).
Verapamil is a lipophilic drug that suggests a 
good effect of the LE in case of overdose (1). For this 
reason, we conducted a laboratory experiment on 
rats with verapamil overdose to which we adminis-
tered only 20% LE in low and high doses as resus-
citation therapy to demonstrate its cardioprotective 
effect.
AIM
The aim of the study is to evaluate the self-car-
dioprotective effect of LE in acute verapamil intoxi-
cation in rats by measurement of the heart rate and 
survival at the recommended dose by ASRA (1.5 mL/
kg) and 7 times the recommended dose (10 mL/kg) 
LE.
MATERIALS AND METHODS
The experiment was performed on 30 healthy 
male Wistar rats with an average weight of 243 g pro-
vided by the vivarium of the Medical University of 
Varna. The procedures for the treatment of animals 
were carried out with the permission and in accor-
dance with the rules for working with experimen-
tal animals of the Ethics Committee of the Bulgarian 
Food Safety Agency (permission for the use of ani-
mals in experiments No. 214, valid until 12.10. 2023).
Experimental Drugs Used
  Isokor® solution for injection, 2.5 mg/mL—
verapamil hydrochloride—a blocker of calcium 
channels to cause arrhythmias and conduction 
disorders (Sopharma AD, Bulgaria)
  Intralipid® lipid emulsion 20% 500 mL (Frese-
nius Kabi AB)
  Saline 0.9% 500 mL (B. Braun Melsungen AG)
  Midazolam Panpharma solution for injection, 5 
mg/mL (Panpharma Laboratories, France)
Methods Used in the Experimental Part with 
Animals
  Instrumental methods: monitoring the heart 
rate of rats using an electrocardiographic mon-
itor Bionett Co, Ltd, model BM3.
  Statistical methods for the laboratory experi-
ment: the statistical analysis was performed us-
ing the statistical functions in Excel 2016 and 
Statistica 7.0. For all statistical analyses, a plau-
sible confidence level of P<0.05, divided into 
three ascending classes, was assumed: P<0.05, 
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P<0.01 (high significance) and P<0.001 (very 
high significance).
Design of the Laboratory Experiment
The animals were divided into five groups as 
follows:
  Group I—healthy controls receiving only saline 
at a dose of 1.5 mL/kg
  Group II—rats pretreated with LE at a dose of 
1.5 mL/kg 5 minutes before injection of vera-
pamil overdose 15 mg/kg 
  Group III—a group of rats poisoned with an 
overdose of verapamil at a dose of 15 mg/kg and 
5 minutes later treated with LE at a dose of 1.5 
mL/kg (recommended dose)
  Group IV—a group of rats poisoned with an 
overdose of verapamil at a dose of 15 mg/kg and 
5 minutes later treated with an LE at a dose of 
10 mL/kg (much higher than the recommend-
ed dose)
  Group V—rats poisoned with 15 mg/kg vera-
pamil overdose
All drugs were administered intraperitoneal-
ly. Heart rate was measured using an electrocardio-
graphic monitor at the 5th, 10th, 15th, 20th, 25th, 30th, 
and 40th minute during drug administration. Sur-
vival was measured in all groups of rats. Verapamil 
overdose of 15 mg/kg was used to assess the severity 
of intoxication (8). Midazolam 4 mg/kg was used at 
the beginning of the study as a sedative agent because 
of its minimal cardiovascular effects (9).
The dose of LE was selected as determined by 
Weinberg and approved by ASRA to be used as an 
antidote for life-threatening lipophilic drug intoxica-
tions, namely a bolus of 1.5 mL/kg (10). 
A group of rats with a verapamil overdose of 15 
mg/kg and such with 7 times the recommended LE 
dose of 10 mL/kg was selected to compare the effects 
at different dosages (11).
A group of animals pretreated with LE was also 
selected, as according to Weinberg pretreatment with 
LE prolongs survival and increases the LD50 of bupi-
vacaine in rats (1).
RESULTS 
Acute intoxication with verapamil. After 15 
minutes of adaptation and 20 minutes after admin-
istration of midazolam, six rats were poisoned with 
a verapamil overdose 15 mg/kg. Table 1 shows the 
heart rate of rats poisoned with verapamil. In poi-
soned rats, the heart rate began to slow down 5 min-
utes after administration of verapamil (P<0.05 vs. 
midazolam heart rate) until it dropped to critical 
levels below 44 beats per minute after 25 minutes 
(P<0.001 vs. verapamil overdose heart rate). In all six 
rats poisoned with verapamil, asystole occurred in 
an average of 43.33 minutes.
Lipid emulsion pretreatment. Six sedated with 
midazolam rats received intraperitoneal LE Intralip-
id 20% 1.5 mL/kg 5 minutes before verapamil poi-
soning. A significant increase in heart rate was ob-
served as early as the 15th minute of acute intoxica-





5 min 10 min 15 min 20 min 25 min 30 min 35 min 40 min 45 min
№1 398 351 227 180 86 29 25 18 10 death
№2 431 412 215 165 91 54 22 15 death
№3 435 374 230 159 95 49 21 17 12 death
№4 419 369 229 177 90 51 29 16 death
№5 425 370 218 153 82 37 19 19 11 death































Table 1. Heart rate of rats poisoned with verapamil
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stabilization within the normal range began after 25 
minutes (P<0.05 vs. verapamil overdose heart rate) 
(Fig. 1). The survival rate in this group was 100%.
Resuscitation with LE at a dose of 1.5 mL/ kg. 
Six rats received a toxic dose of verapamil, 5 min-
utes later a bolus dose of 1.5 mL/kg LE was admin-
istered as the only medication for resuscitation. An-
imals responded to LE as early as the 15th minute 
when the mean heart rate was 233±6.34 beats per 
minute (P<0.05 vs. verapamil overdose heart rate) 
(Fig.2). The pulse rose to a safe value by the 25th min-
ute (P<0.05 vs. verapamil overdose heart rate) and all 
animals were rescued. The survival rate in this group 
was 100%. The mean heart rate at the 30th minute 
was 270±6.69 beats per minute (P<0.01 vs. verapamil 
overdose heart rate). 
Resuscitation with LE at a dose of 10 mL/kg. 
A group of six sedated rats received an overdose of 
verapamil, 5 minutes after а LE at a high dose of 10 
mL/kg was administered as the only medication for 
resuscitation.
After the 10th minute, a gradual increase in the 
animal’s pulse began: 236±10.5 beats per minute at 
the 15th minute (P<0.01 vs. verapamil overdose heart 
rate), and after the 20th minute, it returned to stabi-
lization within the normal range (P<0.001 vs. vera-
pamil overdose heart rate) (Fig. 3). Full recovery is 
also observed in this group. The survival rate in this 
group was 100%. The highest mean heart rate values 
were found in this group: 300±8.67 beats per 30 min-
utes (P<0.001 vs. pretreatment and low dose of LE).
DISCUSSION
The analysis shows that the best results are ob-
served in rats treated with a high dose of LE 10 mL/
kg, which is 7 times higher than the recommended 
for human resuscitation, where the highest mean val-
ues  of the heart rate are found, which confirms its 
positive inotropic effect.
The results coincide with those of leading scien-
tists in the field. First Weinberg (1998) demonstrat-
ed that the cardioprotective effect of LE at a dose of 3 
mL/kg resulted in the alleviation of the cardiac tox-
icity induced by bupivacaine in rats and prevented 
asystole. Later, these findings were also confirmed 
in dogs (12). According to Moshiri (2014) in a hal-
operidol neurotoxicity model in rabbits, the best re-
sults were obtained at a dose of 12 mL/kg, while Har-
Fig. 1. Average heart rate of rats pretreated with LE and 
poisoned with verapamil; interval 0–30 min.
Fig. 2. Average heart rate of rats, poisoned with verapamil 
and treated with LE 1.5 mL/kg; interval 0–30 min.
Fig. 3. Average heart rate of rats, poisoned with verapamil 
and treated with LE 10 mL/kg; interval 0–30 min.
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vey and Cave (2008) recommended 6 mL/kg LE as 
an antidote to local anesthetic toxicity in rabbits (13, 
14). Perez (2008) reported that 18.6 mL/kg LE was the 
optimal dose as an antidote to verapamil toxicity in 
rats (3).
In an experiment with rats, Tebbutt demon-
strated the positive effects of LE on acute intoxica-
tion with drugs that directly exert a cardiotoxic ef-
fect, such as calcium channel blockers, beta blockers, 
and antiarrhythmic drugs. Intralipid 20% resulted 
in a doubling of verapamil LD50 in rats and a reduc-
tion in bradycardia induced by verapamil (15). In the 
propranolol toxicity model, pretreatment with LE re-
sulted in the restoration of an expanded QRS com-
plex and extended the QT interval, as well as led to 
a reduction in the severity of bradycardia in rats. No 
similar therapeutic effect has been observed in aten-
olol poisoning, which is explained by the hydrophilic 
nature of the drug (16).
Different authors suggest different doses, and 
these variations in the dosage of LE are probably due 
to peculiarities in different species of animals (ro-
dents and mammals) as well as differences in fat con-
tent in healthy and intoxicated tissues such as brain 
and heart from which LE should pull the toxin.
CONCLUSION
The present study shows that both pretreatment 
and resuscitation with low or high dose of LE could 
reduce toxicity and prevent dose-dependent asysto-
le induced by the lipophilic drug verapamil. The ad-
ministration of a high dose of 10 mL/kg LE proved 
to be more effective in terms of heart rate in experi-
mental animals.
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